| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/05/2009 | WO2009028543A1 Substituted pyrazole derivative |
| 03/05/2009 | WO2009028457A1 Therapeutic agent for nonalcoholic steatohepatitis |
| 03/05/2009 | WO2009028411A1 Immunosuppression weaning agent comprising tumor cell and antitumor agent using the same |
| 03/05/2009 | WO2009028387A1 Therapeutic agent for cancer with resistance to protease inhibitor |
| 03/05/2009 | WO2009028248A1 Cyclic heptapeptide and use of the same |
| 03/05/2009 | WO2009028220A1 Collagen production promoter |
| 03/05/2009 | WO2009027450A1 Novel bradykinin b1-antagonists |
| 03/05/2009 | WO2009027292A1 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders |
| 03/05/2009 | WO2009027003A1 Use of gestagens in combination with (6s)-5-methyltetrahydrofolate for the therapy of endometriosis with simultaneous reduction of therapy side effects and the reduction of the risk of congenital malformations in case of pregnancy |
| 03/05/2009 | WO2009003694A3 Method for treating diseases related to mitochondrial dysfunction |
| 03/05/2009 | WO2008055068A3 Inhibitors of histone deacetylase |
| 03/05/2009 | WO2008023258A8 Piperidine derivatives |
| 03/05/2009 | WO2007132205A3 Nanoparticle pharmaceutical carrier |
| 03/05/2009 | US20090062382 External preparation for improving coital function |
| 03/05/2009 | US20090062380 Isoflavones for treating mucopolysaccharidoses |
| 03/05/2009 | US20090062377 Anti-cancer combinations |
| 03/05/2009 | US20090062375 Methods and compositions for the treatment of viral diseases |
| 03/05/2009 | US20090062358 Peroxisome proliferator activated receptor alpha agonists |
| 03/05/2009 | US20090062322 Novel Tricyclic Spiropiperidines or Spiropyrrolidines |
| 03/05/2009 | US20090062308 Methods of using sodium channel blockers |
| 03/05/2009 | US20090062249 An intraocular, biodegradable drug delivery system comprising anecortave acetate and a biodegradable glycolic acid-lactic acid copolymer effective in releasing the immunosuppressant into the eye over a period of > 3 weeks; sustained release from a single pellet or a single extruded filament |
| 03/05/2009 | US20090062244 Pharmaceutical composition |
| 03/05/2009 | US20090062241 Highly porous, fast-disintegrating solid dosage form and its way of manufacturing comprising the preparation of a powder and a freezedrying step |
| 03/05/2009 | US20090062229 Method and composition for reducing the expression of rock-ii |
| 03/05/2009 | US20090062228 piRNA and uses related thereto |
| 03/05/2009 | US20090062214 Left-Side Glucose Lipid a Analogue |
| 03/05/2009 | US20090062205 Reconstitution Medium For Protein and Peptide Formulations |
| 03/05/2009 | US20090062200 VEGF-Binding Fusion Proteins and Therapeutic Uses Thereof |
| 03/05/2009 | US20090062197 Sp1 Polypeptides, Modified Sp1 Polypeptides and Uses Thereof |
| 03/05/2009 | US20090062184 Fine particulate preparation comprising complex of nucleic acid molecule and collagen |
| 03/05/2009 | US20090061511 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 03/05/2009 | US20090061048 Delivery and controlled release of encapsulated lipophilic nutrients |
| 03/05/2009 | US20090060996 Formulations of Clopidogrel Bisulphate |
| 03/05/2009 | US20090060992 Preparation of magneto-vesicles with DOPE/DDAB layers |
| 03/05/2009 | US20090060983 Method And Composition For Making An Orally Disintegrating Dosage Form |
| 03/05/2009 | US20090060941 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 03/05/2009 | US20090060937 Immunostimulatory oligonucleotides and uses thereof |
| 03/05/2009 | US20090060911 Enhancement of antibody-mediated immune responses |
| 03/05/2009 | US20090060903 administering Noggin proteins to reduce teratogenicity of antineoplastic agents; antibodies |
| 03/05/2009 | US20090060900 Methods for Screening Compounds That Modulate Lipid Metabolism |
| 03/05/2009 | US20090060896 Gene repair involving in vivo excision of targeting DNA |
| 03/05/2009 | US20090060892 Agents for suppressing hepatic fibrosis |
| 03/05/2009 | US20090060891 High Concentration Self-Microemulsifying Coenzyme Q10 Preparations For Nutritional Use |
| 03/05/2009 | US20090060888 Regulated transcription of targeted genes and other biological events |
| 03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
| 03/05/2009 | US20090060850 Ericacea extracts for combating skin aging |
| 03/05/2009 | US20090060840 Lanthanide Nanoparticle Conjugates and Uses Thereof |
| 03/05/2009 | CA2698129A1 Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent |
| 03/05/2009 | CA2697946A1 New bradykinin b1-antagonists |
| 03/05/2009 | CA2697895A1 Agent for promoting corneal endothelial cell adhesion |
| 03/05/2009 | CA2697663A1 Substituted pyrazole derivative |
| 03/05/2009 | CA2696030A1 Use of gestagens in combination with (6s)-5-methyltetrahydrofolate for therapy of endometriosis with simultaneous reduction of therapy side effects and reduction of the risk of congenital abnormalities at the onset of a pregnancy |
| 03/04/2009 | EP2031057A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 03/04/2009 | EP2031056A1 Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
| 03/04/2009 | EP2030986A1 Polypeptide derivative of parathyroid hormone (PTH) |
| 03/04/2009 | EP2030618A2 Combinations comprising epothilones and anti-metabolites |
| 03/04/2009 | EP2028937A1 Melatonin agonist treatment |
| 03/04/2009 | EP1695983B1 Glucagon-like peptide-1 analogs |
| 03/04/2009 | EP1569630A4 Methods for preventing phototoxic damage during photodynamic therapy |
| 03/04/2009 | EP1551812B1 Mitotic kinesin inhibitors |
| 03/04/2009 | EP1539738B1 Novel aryl- 4-halo-4- heteroarylmethylamino)-methyl -piperidin-1-yl -methanone derivatives, methods for production and use thereof as medicaments |
| 03/04/2009 | EP1519957B1 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 03/04/2009 | EP1499736B1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1463758B1 Mammalian prolactin variants |
| 03/04/2009 | EP1455785B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 03/04/2009 | EP1453507B1 Solubilized topoisomerase poison agents |
| 03/04/2009 | EP1452527B1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 03/04/2009 | EP1432738B1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 03/04/2009 | EP1427720B1 3-substituted-4-pyrimidone derivatives |
| 03/04/2009 | EP1414494B1 Inhibitory antibodies of her3 activity |
| 03/04/2009 | EP1408931B1 Isotonic lipid emulsions |
| 03/04/2009 | EP1392312B1 TRIAZOLO 4,5-d PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 03/04/2009 | EP1294876B1 Eg-vegf nucleic acids and polypeptides and methods of use |
| 03/04/2009 | EP1255845B1 Modified cytokines for use in cancer therapy |
| 03/04/2009 | EP1252322B2 Herpes virus strains for gene therapy |
| 03/04/2009 | EP1140908B1 Triazole compounds with dopamine-d3-receptor affinity |
| 03/04/2009 | EP0988054B1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
| 03/04/2009 | CN101379089A Anti-ILT7 antibody |
| 03/04/2009 | CN101378745A Pharmaceutical composition comprising meglitinide for prevention of hepatic fibrosis |
| 03/04/2009 | CN101378743A Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanaediol derivative as active ingredient, and method for treatment of inflammatory bowel disease |
| 03/04/2009 | CN101378724A Skin-whitening cosmetic |
| 03/04/2009 | CN101376655A Penicillazine derivative, and preparation and use thereof |
| 03/04/2009 | CN101376002A King powder medicine for inducing astringency |
| 03/04/2009 | CN101375999A King powder medicine for calming liver and calming endopathic wind |
| 03/04/2009 | CN101375982A (Compound honeybee and bovine colostrum) medicine for regulating qi |
| 03/04/2009 | CN101375967A (Compound honeybee and bovine colostrums) blood-activating medicine |
| 03/04/2009 | CN101375946A (Compound honeybee and bovine colostrum) medicine for relieving summer-heat |
| 03/04/2009 | CN101375839A Grifola frondosa polysaccharide soft capsules and preparation method thereof |
| 03/04/2009 | CN100465186C A composition and a method for inhibiting platelet aggregation |
| 03/04/2009 | CN100464782C A therapeutic agent for fibromyalgia |
| 03/04/2009 | CN100464749C 5HT4 partial agonist pharmaceutical compositions |
| 03/04/2009 | CN100464743C N-acetylcysteine compositions for the treatment and prevention of drug toxicity |
| 03/04/2009 | CN100464742C NF-kB activation inhibitors |
| 03/04/2009 | CN100464647C A medical agent with amino acids that can increase body temperatures and be used in foods or beverages |
| 03/03/2009 | US7498435 One amine is substituted with a fused heterocyclic ring and the other with a fused heterocyclic ring or phenyl ring, e.g., N2,N4-Bis(3,4-ethylenedioxyphenyl)-5-cyano-2,4-pyrimidinediamine; inhibit IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators such as histamine |
| 03/03/2009 | US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 03/03/2009 | US7498414 Comprising complementarity determining regions; recombinant host cells; fab fragments, fv fragments, diabodies, triabodies, and single domain antibodies; angiogenesis inhibitors; antitumor, antiproliferative, and anticarcinogenic agents; gene expression |
| 03/03/2009 | US7498407 Vascular endothelial cell growth inhibitor, VEGI-192a |
| 03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |